Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Provide Mixed Ratings and Price Targets for Pactiv Evergreen

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finances (2)
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, Goldman Sachs analyst Adam Samuelson reiterated a Neutral rating on Pactiv Evergreen (NASDAQ: PTVE) and raised the price target to $14, up from $12.5. This adjustment marks a series of updates that have seen the price target climb from $11 to $12.5 previously.

Other analysts have also weighed in on PTVE, offering a range of price targets. The average among them is $16.58, with the highest forecast coming in at $19.00. Baird analyst Ghansham Panjabi has similarly maintained a Neutral rating on PTVE, but has upped the price target to $12.

[bs_slider_forecast ticker=”PTVE”]

PTVE Stock Price Plummets by 10%: What Investors Need to Know

On March 4, 2024, PTVE stock experienced a significant drop in price, closing at $13.26, a decrease of $1.49 or 10.10% from the previous market close. Furthermore, in pre-market trading, the stock dropped an additional $0.25.

Investors who were holding PTVE shares may have been taken aback by this sudden drop in price. It is important to note that stock prices can be influenced by a variety of factors, including market conditions, company performance, and investor sentiment. In this case, it appears that something may have caused investors to sell off their PTVE shares, leading to the sharp decline in price.

For investors considering buying or selling PTVE stock, it is essential to conduct thorough research and analysis to understand the reasons behind the price drop and determine whether it is a temporary dip or a sign of more significant issues with the company. Keeping an eye on market trends and news related to PTVE can help investors make informed decisions about their investments.

Currently Playing

PTVE Stock Reports Mixed Performance in Financial Results for 2024: Revenue and Net Income Decrease

On March 4, 2024, PTVE stock experienced a mixed performance as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, PTVE’s total revenue for the year was $5.51 billion, which represented a decrease of 11.41% compared to the previous year. The total revenue for the fourth quarter was $1.27 billion, which remained flat compared to the previous quarter. PTVE reported a loss of $223.00 million for the year, which was a significant decrease of 170.13% compared to the previous year. The net income for the fourth quarter was $21.00 million, which also decreased by 22.22% compared to the previous quarter. Earnings per share (EPS) for PTVE were reported at -$1.26 for the year, representing a decrease of 171.4% compared to the previous year. The EPS for the fourth quarter was $0.11, which remained flat compared to the previous quarter. Overall, PTVE’s financial performance on March 4, 2024, showed a decrease in total revenue and net income compared to the previous year. However, the company was able to maintain its total revenue and net income at the same level compared to the previous quarter. The decrease in EPS for the year was significant, but the EPS for the fourth quarter remained stable. Investors and analysts will likely closely monitor PTVE’s future financial performance to assess the company’s ability to rebound from the recent declines and drive growth in the coming quarters. It will be crucial for PTVE to implement strategic measures to improve its financial metrics and regain investor confidence in the stock.

[stock_market_chart symbol=”PTVE” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: PTVE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023

Finance_ projections

Financial Analysts Bullish on Li Auto Stock

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Lyfts Stock Rises After Upgrade from RBC Capital

Recommended

Uber Stock

Uber Stock: Navigating Conflicting Signals in the Mobility Sector

7 months ago
Gold Stock

Gold’s Historic Surge: A Perfect Storm of Monetary Policy and Momentum

4 months ago
Redcare Pharmacy Stock

Redcare Pharmacy Shares Plunge Amid Deepening Investor Doubts

4 months ago
Healwell AI Stock

Healwell AI’s Full-Year Report: A Pivotal Moment for the Healthcare AI Firm

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Trending

Heidelberg Materials Stock
Analysis

Heidelberg Materials Stock Gains on Strong Fundamentals

by SiterGedge
March 25, 2026
0

After enduring persistent selling pressure for several weeks, shares of Heidelberg Materials opened the week with a...

Glencore Stock

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

March 25, 2026
Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026
Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Heidelberg Materials Stock Gains on Strong Fundamentals
  • Glencore Shares Demonstrate Resilience Amid Copper Market Weakness
  • Energiekontor Stock Gains Momentum from Policy Shifts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com